Galectin Therapeutics (GALT) in Focus: Stock Moves Up 13.2% - Tale of the Tape
December 04 2013 - 8:57AM
Zacks
Galectin Therapeutics,
Inc. (GALT) was a big mover last session, as the company
saw its shares rise over 13% on the day. The move came on solid
volume too with far more shares changing hands than in a normal
session. This breaks the recent trend of the company, as the stock
is now trading above the volatile price range of $5.90 to $9.80 in
the past one-month time frame.
The company has seen one negative revision in the past 30 days and
its Zacks Consensus Estimate moved lower over the same time frame,
suggesting there may be trouble down the road. So make sure to keep
an eye on this stock going forward to see if yesterday’s move
higher can last.
Galectin Therapeutics currently has a Zacks Rank #4 (Sell) while
its Earnings ESP is 0.00%.
Some better-ranked stocks in the generic drugs industry include
Jazz Pharmaceuticals plc (JAZZ), Lannett
Company, Inc. (LCI) and Sucampo Pharmaceuticals,
Inc. (SCMP). All these carry a Zacks Rank #1 (Strong
Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days. Click to get this free report >>
GALECTIN THERAP (GALT): Get Free Report
JAZZ PHARMACEUT (JAZZ): Free Stock Analysis Report
LANNETT INC (LCI): Free Stock Analysis Report
SUCAMPO PHARMAC (SCMP): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
London Clubs (AMEX:LCI)
Historical Stock Chart
From Jul 2024 to Aug 2024
London Clubs (AMEX:LCI)
Historical Stock Chart
From Aug 2023 to Aug 2024